Vivimed Labs Limited (VIVIMEDLAB) — share transfer | 10 July 2026

StockFin.ai

Try Free

Vivimed Labs Limited received a SEBI Regulation 74(5) compliance certificate from its RTA, Aarthi Consultants Private Limited, confirming dematerialization of securities for the quarter ended 30 June 2026. The filing details the RTA's actions in canceling and substituting security certificates as required.

📄 View Original Announcement (PDF)

📊 Stock Analysis — VIVIMEDLAB ✨ Ask AI About This

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹61.27 Cr P/E: -4.4

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

💡 Ask AI about this filing

"How does this share transfer affect Vivimed Labs Limited's outlook?" "What did Vivimed Labs Limited announce on 10 July 2026?" "Is this positive or negative for VIVIMEDLAB?"

Ask AI Free →

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

🔥 Also filed on 10 July 2026

PRIVISCL Privi Speciality Chemicals Limited Annual Report REPRO Repro India Limited Annual Report REPRO Repro India Limited Annual Report SBIN State Bank of India Offer Document SHREECEM SHREE CEMENT LIMITED Corporate Action SUDEEPPHRM Sudeep Pharma Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day